Djibouti vs Viet Nam: HIV expenditure on prevention and treatment
Djibouti
0 constant 2019 US$
in 2022
Viet Nam
0 constant 2019 US$
in 2022
Djibouti rank
101st
Viet Nam rank
101st
HIV expenditure on prevention and treatment over time
- Djibouti
- Viet Nam
How they compare
Djibouti currently reports 0 constant 2019 US$ against 0 constant 2019 US$ in Viet Nam, a difference of 0 constant 2019 US$.
Across all 8 years both countries report, Viet Nam has been ahead every year.
Djibouti ranks 101st and Viet Nam ranks 101st of 144 countries.
Viet Nam has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Djibouti | Viet Nam | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 2.97 million constant 2019 US$ | 100.82 million constant 2019 US$ | 97.85 million constant 2019 US$ | Viet Nam |
| 2010s | 4.39 million constant 2019 US$ | 111.51 million constant 2019 US$ | 107.13 million constant 2019 US$ | Viet Nam |
| 2020s | 0 constant 2019 US$ | 0 constant 2019 US$ | 0 constant 2019 US$ | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv expenditure on prevention and treatment, Djibouti or Viet Nam?
- Djibouti, at 0 constant 2019 US$ against 0 constant 2019 US$ in Viet Nam as of 2022.
- What is the difference in hiv expenditure on prevention and treatment between Djibouti and Viet Nam?
- 0 constant 2019 US$, with Djibouti ahead.
- How many years of comparable data are there for Djibouti and Viet Nam?
- 8 years are reported by both, from 2007 to 2022.
- How do Djibouti and Viet Nam rank globally for hiv expenditure on prevention and treatment?
- Djibouti ranks 101st and Viet Nam ranks 101st of 144 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data, published as HIV expenditure on prevention and treatment. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Total in-country spending on HIV programs and services.